About Us

Developing workflows, infrastructure and standards to support the use of genomic data in a clinical setting.

The sequencing and analysis of cancer genomes can transform diagnosis and treatment options. The process relies on scalable, reproducible and accurate interrogation of data in timeframes that matter to patients, supported by the right infrastructure.

Professor Oliver Hofmann's Genomics Platform Group works in close collaboration with the international bioinformatics community to develop and maintain analytical workflows to identify genomic alterations. For rare and challenging cancer cases, it is vital that any genomic data can be confidently compared to local and international data sets analysed under the same standards — enabling researchers and clinicians to process, analyse and aggregate large-scale sequencing data.

The Genomics Platform Group is a national leader in the establishment of infrastructure needed to manage and share huge sets of uniform data.

They work closely with multiple partners around the world including the Global Alliance for Genomics and Health (GA4GH), Genomics England and the Hartwig Medical Foundation to achieve greater international coordination and enable the exchange of data between large scale cancer cohorts.